Navigating the Future of Cutaneous Squamous Cell Carcinoma (cSCC): An Expert Discussion on Modern Immunotherapy - Episode 4
Panelists discuss when cSCC can be managed within dermatology and when multidisciplinary referral is warranted.
Panelists explain that small, well-differentiated, low-risk tumors are often treated effectively in dermatology clinics with surgical excision or Mohs micrographic surgery. However, tumors with deep invasion, perineural spread, or involvement of cosmetically sensitive areas may require collaboration with head and neck surgery, radiation oncology, or reconstructive teams.
They emphasize that referral decisions depend not only on tumor biology but also on patient comorbidities, functional concerns, and access to specialized care. Efficient referral pathways—supported by institutional protocols—help avoid treatment gaps and ensure appropriate sequencing.
In summary, defining the threshold between local management and multidisciplinary intervention is key to optimizing both safety and outcomes. Clear communication across specialties remains the foundation of coordinated care.